December 22, 2005
Sub: Discontinuance of Buyback of the shares of
Glaxo SmithKline Pharmaceuticals Ltd. (Scrip Code: 500660)
In continuation of Exchange
Notice No: 20050506 - 2 dated May 06, 2005, the members are hereby informed
that Glaxo SmithKline Pharmaceuticals
Ltd. (Scrip Code: 500660) will
discontinue with the scheme
of buyback of its fully paid-up
equity shares of face value of Rs.10/- each from the Open Market through the
trading mechanism of the Exchange.
Accordingly, the scheme of buyback of shares of Glaxo SmithKline Pharmaceuticals Ltd. will not be available
in Physical as well as Demat form with effect from December 23, 2005 and
trading under the following scrip code for physical mode will be suspended:
Scrip Code
|
Name Of the
Securities
|
Suspended From
|
|
532632
|
Glaxo SmithKline
Pharmaceuticals Ltd.
|
23/12/2005
|
Neha Gada
Manager
Dept. of Corporate Services